← back to search

Yan Wu

University of Alabama at Birmingham · US
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research focused on Mesenchymal stem cell and Cancer research, with related work in Cell biology, Programmed cell death, Immunosuppression. Notable publications include 'Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates', 'The Mechanism of Ferroptosis and Applications in Tumor Treatment', and 'Leptin Signaling Is Required for Augmented Therapeutic Properties of Mesenchymal Stem Cells Conferred by Hypoxia Preconditioning'.
h-index
citations
667
works
15
NIH funding
primary concept
email

Recent publications

High Expression of <i>ZFP42</i> Improves Early Development of Pig Embryos Produced by Handmade Cloning
Cellular Reprogramming 2024cited by 1position: middledoi
Activation-induced cell death in CAR-T cell therapy
Human Cell 2022cited by 43position: middledoi
Cell Adhesion Molecule CD99 in Cancer Immunotherapy
Current Molecular Medicine 2022cited by 12position: middledoi
The application of oncolytic viruses in cancer therapy
Biotechnology Letters 2021cited by 8position: middledoi
The Mechanism of Ferroptosis and Applications in Tumor Treatment
Frontiers in Pharmacology 2020cited by 105position: lastdoi
A polybasic domain in aPKC mediates Par6-dependent control of membrane targeting and kinase activity
The Journal of Cell Biology 2020cited by 41position: middledoi
Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates
Circulation Research 2018cited by 144position: middledoi
ANG II facilitated CD11+Ly6Chi cells reprogramming into M1-like macrophage through Erk1/2 or p38-Stat3 pathway and involved in EAM
Journal of Leukocyte Biology 2018cited by 14position: middledoi
The mir-675-5p regulates the progression and development of pancreatic cancer via the UBQLN1-ZEB1-mir200 axis
Oncotarget 2017cited by 39position: middledoi
Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers
Tumor Biology 2016cited by 54position: middledoi
MiR-211/STAT5A Signaling Modulates Migration of Mesenchymal Stem Cells to Improve its Therapeutic Efficacy
Stem Cells 2016cited by 48position: middledoi
Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies
Critical Reviews in Oncology/Hematology 2016cited by 40position: middledoi
PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells
Oncotarget 2016cited by 18position: firstdoi
Corrigendum
Stem Cells 2015cited by 26position: middledoi
Leptin Signaling Is Required for Augmented Therapeutic Properties of Mesenchymal Stem Cells Conferred by Hypoxia Preconditioning
Stem Cells 2014cited by 74position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yongchang Chen · Sun Yat-sen University Cancer Center3 papers (2016–2016)Xiaoyuan Yao · Southwest University3 papers (2016–2016)Xinyang Hu · Implant Sciences (United States)3 papers (2014–2016)Yinchuan Xu · University of Alabama at Birmingham3 papers (2014–2016)Qinggang Xu · Jiangsu University3 papers (2021–2022)Keith A. Webster · University of Miami3 papers (2014–2016)Hong Yu · Wuhan University3 papers (2014–2016)Hai Qian · University of Iowa2 papers (2016–2016)Huiqiang Chen · University of Technology Sydney2 papers (2014–2015)Ting Lan · Jiangsu University2 papers (2016–2016)Rongrong Wu · South China Agricultural University2 papers (2014–2016)Huan Tian · Jiangsu University2 papers (2021–2022)Feng Yu · Jiangsu University2 papers (2021–2022)Kwaku Appiah‐Kubi · Jiangsu University2 papers (2016–2016)Hailing Zhang · Shandong University of Technology2 papers (2022–2022) · 2 papers (2022–2022)Min Wu · Second Military Medical University2 papers (2016–2016)Han Chen · Fudan University2 papers (2014–2015)Ling Zhang · Hospital for Sick Children2 papers (2014–2016)Guodong Liu · Pennsylvania State University2 papers (2022–2022)